Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 23Lymphoma 16Osteosarcoma 11Lymphoma, Large B-Cell, Diffuse 11Hodgkin Disease 11Testicular Neoplasms 10Lymphoma, Non-Hodgkin 10Teratoma 8Ovarian Neoplasms 7Testicular Germ Cell Tumor 6Neuroectodermal Tumors, Primitive, Peripheral 6Neoplasms 6Burkitt Lymphoma 6Recurrence 5Endodermal Sinus Tumor 5Central Nervous System Neoplasms 5Carcinoma, Embryonal 5Lymphoma, Large-Cell, Anaplastic 4Seminoma 3Rhabdomyosarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Germ Cell Cancer 3Neurofibrosarcoma 3Lymphoma, Mantle-Cell 3Lymphoma, B-Cell 3Histiocytoma, Malignant Fibrous 3Fibrosarcoma 3Vomiting 2Sarcoma, Synovial 2Sarcoma, Alveolar Soft Part 2

Interventions

Dexamethasone 17Palonosetron 13Aprepitant 13Ondansetron 12Calcium Dobesilate 12Granisetron 7dexamethasone acetate 5Doxorubicin 5Cyclophosphamide 4fosaprepitant 3dexamethasone 21-phosphate 3Vincristine 3Olanzapine 3Cisplatin 3Therapeutics 2Sugars 2Radiotherapy 2Mesna 2Lorazepam 2Ifosfamide 2Fluorouracil 2Dronabinol 2Diphenhydramine 2rolapitant 1netupitant 1isatuximab 1ginger extract 1dolasetron 1casopitant 1auricularum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Nausea × Ifosfamide × Clear all
NCT01490060 2016-04-11

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

M.D. Anderson Cancer Center

Phase NA Completed
47 enrolled 6 charts
Sarcoma

Nausea, Neoplasms, Sarcoma, Vomiting

NCT00410488 2013-03-22

Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)

M.D. Anderson Cancer Center

Phase NA Completed
51 enrolled 5 charts
Sarcoma

Nausea, Sarcoma, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡